ProEncia Biotechnology Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-26.
ProEncia Biotechnology Inc. filed a Form D notice of an exempt securities offering with the SEC on August 26, 2026. The filing reports $1.51M sold. Its industry group is Biotechnology. It names Tapos Ghosh (Executive Officer, Director), Tarun Ghosh (Director), Austin Loeb (Executive Officer) (SEC Form D, August 26, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to ProEncia Biotechnology Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like ProEncia Biotechnology Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-26 · the record
Pitching, partnering or investing alongside them? See who really runs and owns ProEncia Biotechnology Inc.
Free to see. No signup.
More on the people and the money behind ProEncia Biotechnology Inc., from the filings we hold.
Biotechnology raises by companies based in Minnesota, filed within 90 days of this one, largest first.
Get an email when ProEncia Biotechnology Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when ProEncia Biotechnology Inc. raises, hires or launches. No email unless you switch it on.
Watch ProEncia Biotechnology Inc. →Get the full cited report on ProEncia Biotechnology Inc.
What the filing shows about ProEncia Biotechnology Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ProEncia Biotechnology Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives ProEncia Biotechnology Inc.'s address as 9094 Princeton Road, Woodbury, MN 55125.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on ProEncia Biotechnology Inc. See pricing
ProEncia Biotechnology Inc. is a registered filer with the SEC (CIK 2103044) and has filed since 2026-08-26. 1 filing is on record, the latest on 2026-08-26.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
ProEncia Biotechnology Inc.'s Form D of 2026-08-26 names Tapos Ghosh, Tarun Ghosh, Austin Loeb and 1 more as its officers, directors or promoters.
Its new offerings report $1.51M sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $1.51M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Tapos Ghosh is named as Executive Officer and Director on the Form D that ProEncia Biotechnology Inc. filed with the SEC on 26 August 2026, one of 4 people that filing names.
Tarun Ghosh is named as Director on the Form D that ProEncia Biotechnology Inc. filed with the SEC on 26 August 2026, one of 4 people that filing names.
Austin Loeb is named as Executive Officer on the Form D that ProEncia Biotechnology Inc. filed with the SEC on 26 August 2026, one of 4 people that filing names.
Thomas Hoover is named as Executive Officer on the Form D that ProEncia Biotechnology Inc. filed with the SEC on 26 August 2026, one of 4 people that filing names.
4 people named on the filing — 3 holding an executive role and 1 as a director only.
Named as of the 2026-08-26 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about ProEncia Biotechnology Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ProEncia Biotechnology Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ProEncia Biotechnology Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ProEncia Biotechnology Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind ProEncia Biotechnology Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for ProEncia Biotechnology Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-08-24 · Biotech raises, week of 2026-08-24
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/proencia-biotechnology-inc-form-d-26000001